Researchers found that the compound, called cannabidiol, had the ability to 'switch off' the gene responsible for metastasis in an aggressive form of breast cancer. Importantly, this substance does not produce the psychoactive properties of the cannabis plant.
Last year they published a study that found a similar effect in mice. Now they say they are on the verge of publishing further animal study results that expand these results further.
Speaking to the San Francisco Chronicle, study co-leader Dr Sean McAllister, said: 'The preclinical trial data is very strong, and there's no toxicity. There's really a lot or research to move ahead with and to get people excited.'
Authorities in France have placed more than a third of the country under a red heat...
One morning early last July, Micha Bitsinnie arrived at work to an onslaught of messages from...
